查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613031

全球可卡因使用障礙市場（依治療方法、藥物、治療環境、產業）：未來預測（2025-2030）

Cocaine Use Disorder Market by Therapeutic Approaches (Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management), Medications (Anticonvulsants, Antidepressants, Antipsychotics), Treatment Setting - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023 年可卡因使用障礙市值為 13.2 億美元，預計到 2024 年將達到 13.9 億美元，複合年成長率為 6.21%，到 2030 年將達到 20.1 億美元。

可卡因使用障礙（CUD）是一個重大的公共衛生問題，其特徵是強迫性使用可卡因，導致臨床上嚴重的損害和痛苦。 CUD的範圍主要涉及製藥公司、研究機構、醫療保健提供者和復健中心，以開發針對CUD的治療方法和療法。解決 CUD 問題的必要性在於其高昂的社會成本，包括醫療成本、生產力損失和法律影響。因此，需要綜合應用，包括藥物輔助治療、行為療法以及包括遺傳和神經生物學研究在內的創新方法。最終用途主要包括醫院、復健設施，甚至旨在擴大受影響人群範圍的推廣遠端醫療平台。

主要市場統計
基準年[2023] 13.2億美元
預計年份 [2024] 13.9億美元
預測年份 [2030] 20.1億美元
複合年成長率（%） 6.21%

市場成長要素包括對藥物濫用障礙認知的提高、醫療基礎設施的加強以及對新治療方法的持續研究。 CUD 日益增加的社會負擔，加上不斷進步的健康政策，正在推動對更有效干預策略的需求。數位健康技術和人工智慧主導的個人化治療計劃的整合凸顯了該市場的治療機會。公司可以投資行動應用程式來監控和促進患者的依從性，以及用於早期檢測和預防策略的人工智慧工具。然而，嚴格的法律規範、圍繞成癮的社會恥辱以及複雜的行為健康變數導致的臨床試驗挑戰等限制因素可能會阻礙市場成長。

該市場提供了強大的創新途徑，包括探索神經調節技術和開發針對可卡因成癮的特定大腦通路的非成癮治療方法。此外，與高科技公司的跨行業合作，特別是那些專注於人工智慧和機器學習的公司，可以加強研發舉措。透過持續創新和跨學科夥伴關係，將開發巨大的潛力，旨在治療和理解可卡因成癮的多方面方面。將此舉措擴展到全球夥伴關係還可以減少地區差異並加速市場成熟。

市場動態：揭示快速發展的可卡因使用障礙市場的關鍵市場洞察

可卡因使用障礙市場正因供需的動態互動而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 可卡因使用的全球流行
    • 提高對需要治療可卡因使用障礙的成癮問題的認知和社會接受度
    • 政府和私人資助成癮治療項目
  • 市場限制因素
    • 專業醫療保健提供者的數量有限以及與可卡因成癮相關的社會恥辱
  • 市場機會
    • 使用利用遺傳和心理社會標記的創新醫療方法進行個人化治療
    • 人工智慧和機器學習在預測治療結果和透過數位平台增強病人參與的應用
  • 市場挑戰
    • 世界各地人群治療效果的監管障礙與差異

波特的五力：駕馭可卡因使用障礙市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解可卡因使用障礙市場的外部影響

外部宏觀環境因素在塑造可卡因使用障礙市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解可卡因使用障礙市場的競爭格局

可卡因使用障礙市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：可卡因使用障礙市場的供應商績效評估

FPNV 定位矩陣是評估古柯鹼使用障礙市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製可卡因使用障礙市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對可卡因使用障礙市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估市場範圍和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析最近的產品發布、開拓的地區、關鍵產業進展以及塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1. 目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 哪些收益來源和策略機會推動供應商的進入/退出策略？

目錄

第1章簡介

第2章 分析方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地可卡因使用量增加
      • 提高對成癮問題的認知和社會接受度以及治療可卡因使用障礙的需要
      • 為成癮治療計畫提供公共和私人資金
    • 抑制因素
      • 缺乏專業的醫療保健提供者以及與可卡因成癮相關的社會恥辱
    • 機會
      • 一種創新的醫療方法，利用遺傳和心理社會標記來提供個人化治療。
      • 應用人工智慧和機器學習來預測治療結果並透過數位平台增強患者參與度
    • 任務
      • 世界各地人群的監管障礙和治療效果差異
  • 市場區隔分析
    • 治療環境：對住宅復健設施的興趣日益濃厚
    • 藥物：治療可卡因使用障礙時對精神興奮劑的基於需求的偏好
  • 波特五力分析
  • PESTEL分析
    • 政治因素
    • 經濟因素
    • 社會因素
    • 技術因素
    • 法律因素
    • 環境因素

第6章 可卡因使用疾患的市場治療：依治療方法

  • 行為療法
  • 認知行為療法
  • 緊急管理
  • 藥物治療
  • 增加動力

第7章 可卡因使用疾患市場：依藥物分類

  • 抗驚厥藥
  • 抗憂鬱症
  • 抗精神病藥
  • 精神興奮劑

第8章可卡因使用障礙市場：依治療環境

  • 醫院治療計劃
  • 住院復健中心
  • 日間復健中心
  • 居家復健設施

第9章美洲可卡因使用障礙市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

    第10章亞太地區可卡因使用疾患市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的可卡因使用疾患市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • 科學家研發出古柯鹼疫苗
    • FDA核准新的Buprenornhine治療鴉片類藥物使用障礙
  • 戰略分析和建議

公司名單

  • Alkermes PLC
  • Alnylam Pharmaceuticals, Inc.
  • Camurus AB
  • Indivior PLC
  • Johnson & Johnson Services, Inc.
  • KemPharm, Inc.
  • Novartis International AG
  • Orexo AB
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Revive Therapeutics Ltd.
  • Sage Therapeutics, Inc.
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals USA, Inc.
  • Viatris Inc.
Product Code: MRR-F97DD5A7E128

The Cocaine Use Disorder Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 6.21%, to USD 2.01 billion by 2030.

Cocaine Use Disorder (CUD) is a significant public health issue characterized by the compulsive use of cocaine, leading to clinically significant impairment or distress. Its market scope primarily involves pharmaceutical companies, research institutions, healthcare providers, and rehabilitation centers developing treatments and therapies targeted at CUD. The necessity of addressing CUD is underscored by its high societal costs, ranging from healthcare expenses to lost productivity and legal implications. This calls for comprehensive applications, such as medication-assisted treatments, behavioral therapies, and innovative approaches involving genetic and neurobiological research. End-use primarily spans hospitals, rehabilitation facilities, and even telemedicine platforms aiming to expand outreach for affected individuals.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 2.01 billion
CAGR (%) 6.21%

Market growth factors include increasing awareness about substance use disorders, enhanced healthcare infrastructure, and ongoing research into novel treatment methodologies. The rising societal burden of CUD, combined with progressive healthcare policies, propels the demand for more effective intervention strategies. Opportunities in this market are highlighted by the integration of digital health technologies and AI-driven personalized treatment plans. Companies could invest in mobile applications for monitoring and encouraging patient adherence or AI tools for early detection and prevention strategies. However, limitations such as stringent regulatory frameworks, the social stigma surrounding addiction, and challenges in clinical trials due to complex behavioral health variables may impede market growth.

The market offers prime avenues for innovation, including the exploration of neuromodulation techniques and the development of non-addictive therapeutics that target specific brain pathways involved in cocaine addiction. Furthermore, cross-industry collaborations, especially with tech firms focusing on AI and machine learning, could bolster research and development initiatives. The nature of the market is one of cautious optimism, with considerable potential harnessed through sustained innovation and multi-disciplinary partnerships aimed at both treating and understanding the multifaceted aspects of cocaine addiction. Expanding initiatives to include global partnerships can also alleviate regional disparities and accelerate market maturity.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cocaine Use Disorder Market

The Cocaine Use Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cocaine use worldwide
    • Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
    • Governmental and private funding for addiction treatment programs
  • Market Restraints
    • Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
  • Market Opportunities
    • Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
    • Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
  • Market Challenges
    • Regulatory hurdles and variability in treatment effectiveness across populations worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Cocaine Use Disorder Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cocaine Use Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cocaine Use Disorder Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cocaine Use Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cocaine Use Disorder Market

A detailed market share analysis in the Cocaine Use Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cocaine Use Disorder Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cocaine Use Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cocaine Use Disorder Market

A strategic analysis of the Cocaine Use Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cocaine Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Alkermes PLC, Alnylam Pharmaceuticals, Inc., Camurus AB, Indivior PLC, Johnson & Johnson Services, Inc., KemPharm, Inc., Novartis International AG, Orexo AB, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Revive Therapeutics Ltd., Sage Therapeutics, Inc., Shionogi & Co., Ltd., Teva Pharmaceuticals USA, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Cocaine Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapeutic Approaches, market is studied across Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management, Medication-Assisted Treatment, and Motivational Enhancement.
  • Based on Medications, market is studied across Anticonvulsants, Antidepressants, Antipsychotics, and Psychostimulants.
  • Based on Treatment Setting, market is studied across Hospital-Based Treatment Programs, Inpatient Rehabilitation Centers, Outpatient Rehabilitation Centers, and Residential Rehabilitation Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cocaine use worldwide
      • 5.1.1.2. Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
      • 5.1.1.3. Governmental and private funding for addiction treatment programs
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
      • 5.1.3.2. Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and variability in treatment effectiveness across populations worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Setting: Increasing preference for residential rehabilitation facilities
    • 5.2.2. Medications: Need based preference for psychostimulants for treatment of cocaine use disorder
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cocaine Use Disorder Market, by Therapeutic Approaches

  • 6.1. Introduction
  • 6.2. Behavioral Therapies
  • 6.3. Cognitive-Behavioral Therapy
  • 6.4. Contingency Management
  • 6.5. Medication-Assisted Treatment
  • 6.6. Motivational Enhancement

7. Cocaine Use Disorder Market, by Medications

  • 7.1. Introduction
  • 7.2. Anticonvulsants
  • 7.3. Antidepressants
  • 7.4. Antipsychotics
  • 7.5. Psychostimulants

8. Cocaine Use Disorder Market, by Treatment Setting

  • 8.1. Introduction
  • 8.2. Hospital-Based Treatment Programs
  • 8.3. Inpatient Rehabilitation Centers
  • 8.4. Outpatient Rehabilitation Centers
  • 8.5. Residential Rehabilitation Facilities

9. Americas Cocaine Use Disorder Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cocaine Use Disorder Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cocaine Use Disorder Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Scientists Develop a Vaccine For Cocaine
    • 12.3.2. FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alkermes PLC
  • 2. Alnylam Pharmaceuticals, Inc.
  • 3. Camurus AB
  • 4. Indivior PLC
  • 5. Johnson & Johnson Services, Inc.
  • 6. KemPharm, Inc.
  • 7. Novartis International AG
  • 8. Orexo AB
  • 9. Otsuka Pharmaceutical Co., Ltd.
  • 10. Pfizer Inc.
  • 11. Revive Therapeutics Ltd.
  • 12. Sage Therapeutics, Inc.
  • 13. Shionogi & Co., Ltd.
  • 14. Teva Pharmaceuticals USA, Inc.
  • 15. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. COCAINE USE DISORDER MARKET RESEARCH PROCESS
  • FIGURE 2. COCAINE USE DISORDER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COCAINE USE DISORDER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COCAINE USE DISORDER MARKET DYNAMICS
  • TABLE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COGNITIVE-BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY CONTINGENCY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATION-ASSISTED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY HOSPITAL-BASED TREATMENT PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY RESIDENTIAL REHABILITATION FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 150. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023